Peter de Waele
Algemeen Directeur bij Advanced Therapies Consulting Limited
Actieve functies van Peter de Waele
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Advanced Therapies Consulting Limited | Algemeen Directeur | - | - |
Loopbaan van Peter de Waele
Eerdere bekende functies van Peter de Waele
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CELYAD ONCOLOGY SA | Hoofd Techniek/Wetenschap/O&O | 01-11-2010 | - |
| Corporate Officer/Principal | 01-11-2010 | - | |
| Xcellentis NV | Operationeel Directeur | 01-01-2006 | 01-01-2006 |
| Oprichter | 01-01-2006 | 01-01-2006 | |
| Ghent University | Corporate Officer/Principal | 01-01-1986 | 01-01-1986 |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | - | - |
Opleiding van Peter de Waele
| Ghent University | Doctorate Degree |
Statistieken
Internationaal
| België | 5 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Chief Operating Officer | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CELYAD ONCOLOGY SA | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| Xcellentis NV | Health Technology |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Health Technology |
| Advanced Therapies Consulting Limited |
- Beurs
- Insiders
- Peter de Waele
- Ervaring
